FDA NDC
Alogliptin and Pioglitazone
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 45802-260
- Proprietary name
- Alogliptin and Pioglitazone
- Nonproprietary name
- Alogliptin Benzoate and Pioglitazone hydrochloride
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- TABLET, FILM COATED
- Strength
- 12.5 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted Alogliptin Benzoate and Pioglitazone hydrochloride?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.